Thermo Fisher Scientific (TMO) said Tuesday that it has agreed to acquire Solventum's (SOLV) Purification & Filtration business for $4.1 billion in cash.
Thermo said the deal, which is set to be completed by the end of the year, is expected to be dilutive to adjusted EPS by $0.06.
In a separate statement, Solventum said it expects the deal to be neutral to EPS this year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.